263 related articles for article (PubMed ID: 33879792)
1. An integrative analysis of the age-associated multi-omic landscape across cancers.
Chatsirisupachai K; Lesluyes T; Paraoan L; Van Loo P; de Magalhães JP
Nat Commun; 2021 Apr; 12(1):2345. PubMed ID: 33879792
[TBL] [Abstract][Full Text] [Related]
2. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
[TBL] [Abstract][Full Text] [Related]
3. Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival.
Chen Y; Sadasivan SM; She R; Datta I; Taneja K; Chitale D; Gupta N; Davis MB; Newman LA; Rogers CG; Paris PL; Li J; Rybicki BA; Levin AM
BMC Med Genomics; 2020 Aug; 13(1):116. PubMed ID: 32819446
[TBL] [Abstract][Full Text] [Related]
4. Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer.
Wrzeszczynski KO; Varadan V; Byrnes J; Lum E; Kamalakaran S; Levine DA; Dimitrova N; Zhang MQ; Lucito R
PLoS One; 2011; 6(12):e28503. PubMed ID: 22174824
[TBL] [Abstract][Full Text] [Related]
5. Integrated Genomics for Pinpointing Survival Loci within Arm-Level Somatic Copy Number Alterations.
Roy DM; Walsh LA; Desrichard A; Huse JT; Wu W; Gao J; Bose P; Lee W; Chan TA
Cancer Cell; 2016 May; 29(5):737-750. PubMed ID: 27165745
[TBL] [Abstract][Full Text] [Related]
6. Immunodeficiency in Pancreatic Adenocarcinoma with Diabetes Revealed by Comparative Genomics.
Yan Y; Gao R; Trinh TLP; Grant MB
Clin Cancer Res; 2017 Oct; 23(20):6363-6373. PubMed ID: 28684632
[No Abstract] [Full Text] [Related]
7. Molecular correlates and therapeutic targets in T cell-inflamed versus non-T cell-inflamed tumors across cancer types.
Bao R; Stapor D; Luke JJ
Genome Med; 2020 Oct; 12(1):90. PubMed ID: 33106165
[TBL] [Abstract][Full Text] [Related]
8. An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer.
Chari R; Coe BP; Vucic EA; Lockwood WW; Lam WL
BMC Syst Biol; 2010 May; 4():67. PubMed ID: 20478067
[TBL] [Abstract][Full Text] [Related]
9. Integrative epigenetic and genetic pan-cancer somatic alteration portraits.
Salas LA; Johnson KC; Koestler DC; O'Sullivan DE; Christensen BC
Epigenetics; 2017 Jul; 12(7):561-574. PubMed ID: 28426276
[TBL] [Abstract][Full Text] [Related]
10. Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia.
Haider S; McIntyre A; van Stiphout RG; Winchester LM; Wigfield S; Harris AL; Buffa FM
Genome Biol; 2016 Jun; 17(1):140. PubMed ID: 27358048
[TBL] [Abstract][Full Text] [Related]
11. Age-related somatic mutations in the cancer genome.
Milholland B; Auton A; Suh Y; Vijg J
Oncotarget; 2015 Sep; 6(28):24627-35. PubMed ID: 26384365
[TBL] [Abstract][Full Text] [Related]
12. Identification of driver copy number alterations in diverse cancer types and application in drug repositioning.
Zhou W; Zhao Z; Wang R; Han Y; Wang C; Yang F; Han Y; Liang H; Qi L; Wang C; Guo Z; Gu Y
Mol Oncol; 2017 Oct; 11(10):1459-1474. PubMed ID: 28719033
[TBL] [Abstract][Full Text] [Related]
13. Genomic and epigenetic aberrations of chromosome 1p36.13 have prognostic implications in malignancies.
Naderi A
Chromosome Res; 2020 Dec; 28(3-4):307-330. PubMed ID: 32816122
[TBL] [Abstract][Full Text] [Related]
14. Pan-cancer patterns of somatic copy number alteration.
Zack TI; Schumacher SE; Carter SL; Cherniack AD; Saksena G; Tabak B; Lawrence MS; Zhsng CZ; Wala J; Mermel CH; Sougnez C; Gabriel SB; Hernandez B; Shen H; Laird PW; Getz G; Meyerson M; Beroukhim R
Nat Genet; 2013 Oct; 45(10):1134-40. PubMed ID: 24071852
[TBL] [Abstract][Full Text] [Related]
15. Genomic basis for RNA alterations in cancer.
; Calabrese C; Davidson NR; Demircioğlu D; Fonseca NA; He Y; Kahles A; Lehmann KV; Liu F; Shiraishi Y; Soulette CM; Urban L; Greger L; Li S; Liu D; Perry MD; Xiang Q; Zhang F; Zhang J; Bailey P; Erkek S; Hoadley KA; Hou Y; Huska MR; Kilpinen H; Korbel JO; Marin MG; Markowski J; Nandi T; Pan-Hammarström Q; Pedamallu CS; Siebert R; Stark SG; Su H; Tan P; Waszak SM; Yung C; Zhu S; Awadalla P; Creighton CJ; Meyerson M; Ouellette BFF; Wu K; Yang H; ; Brazma A; Brooks AN; Göke J; Rätsch G; Schwarz RF; Stegle O; Zhang Z;
Nature; 2020 Feb; 578(7793):129-136. PubMed ID: 32025019
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive genomic characterization of head and neck squamous cell carcinomas.
Cancer Genome Atlas Network
Nature; 2015 Jan; 517(7536):576-82. PubMed ID: 25631445
[TBL] [Abstract][Full Text] [Related]
17. The multi-omic landscape of transcription factor inactivation in cancer.
Teschendorff AE; Zheng SC; Feber A; Yang Z; Beck S; Widschwendter M
Genome Med; 2016 Aug; 8(1):89. PubMed ID: 27562343
[TBL] [Abstract][Full Text] [Related]
18. Effects of TP53 mutational status on gene expression patterns across 10 human cancer types.
Parikh N; Hilsenbeck S; Creighton CJ; Dayaram T; Shuck R; Shinbrot E; Xi L; Gibbs RA; Wheeler DA; Donehower LA
J Pathol; 2014 Apr; 232(5):522-33. PubMed ID: 24374933
[TBL] [Abstract][Full Text] [Related]
19. Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas.
Castro-Vega LJ; Letouzé E; Burnichon N; Buffet A; Disderot PH; Khalifa E; Loriot C; Elarouci N; Morin A; Menara M; Lepoutre-Lussey C; Badoual C; Sibony M; Dousset B; Libé R; Zinzindohoue F; Plouin PF; Bertherat J; Amar L; de Reyniès A; Favier J; Gimenez-Roqueplo AP
Nat Commun; 2015 Jan; 6():6044. PubMed ID: 25625332
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer.
Liu N; Wu Y; Cheng W; Wu Y; Wang L; Zhuang L
BMC Cancer; 2021 Apr; 21(1):460. PubMed ID: 33902514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
